Join Georgia Bio & BIO Alabama on Thursday, April 23rd at 9:00 am CST/10:00 am EST to hear from our national partners BIO & PhRMA and attorneys from Bradley for a federal policy update.
The speakers will discuss recent passed legislation including:
- Supplemental I – Coronavirus Supplemental
- Supplemental II – Families First Coronavirus Response Act (HR 6201)
- Supplemental III – Coronavirus Aid, Relief, and Economic Security (CARES Act)
- Impact on businesses, share insights into the Supplemental IV – “CARES 2.0”, and President Trump's “Buy American” mandates to the medical equipment and biopharmaceutical sector, among other issues.
Bart Forsyth, Pharmaceutical Research and Manufacturers of America (PhRMA)
Jamie Gregorian, Biotechnology Innovation Organization
For more information, visit the BIO Alabama website.